AbbVie today announced a $1.4 billion investment to build a new drug production facility on a 185-acre campus in Durham County, where the company expects to employ 734 people. The company’s ...
With roots in the research labs at North Carolina State University, ChromaGenix has opened a new $35 million, ...
Hosted by the North Carolina Biotechnology Center and its Piedmont Triad Regional Advisory Committee, Triad BioNight is ...
NCBioImpact, a public/private partnership created to bring together key resources to produce world-class biopharma ...
Join Bytes2Bites RTP for a talk by NVIDIA’s Ben Busby on accelerated bioinformatics and AI‑driven genotype–phenotype modeling.
Whether you are new to networking or a seasoned veteran, don't miss out on this opportunity to make quality connections in North Carolina's life sciences ecosystem. All life sciences professionals are ...
Incyclix Bio, LLC, a cell cycle control company developing INX-315, a novel, potent and selective CDK2 inhibitor for the treatment of advanced and resistant cancer, today announced that it has raised ...
About 2 million Americans have a heart condition called “ paroxysmal supraventricular tachycardia ,” or PSVT. An electrical problem in the heart causes it to beat very fast—150-220 beats per ...
Whether you're a faculty researcher exploring a university spinout, a student with a startup idea, or an entrepreneur actively building a company, this session will empower you to grow, raise capital, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results